Changes in presynaptic protein NACP/α-synuclein in an ischemic gerbil hippocampus

Brain Research

Volumn 788, Issue 1-2, 1998, Pages 311-314

  Ishimaru, Hirohisa ^a   Uéda, Kenji ^b   Takahashi, Akira ^a   Maruyama, Yuji ^a  

^a GUNMA UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Hippocampus; Ischemia; NAC; NACP; Presynaptic protein; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID PRECURSOR PROTEIN; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; GERBIL; HIPPOCAMPUS; MALE; NONHUMAN; PATHOGENESIS; PRESYNAPTIC NERVE; PRIORITY JOURNAL;

ALPHA-SYNUCLEIN; AMYLOID; ANIMALS; GERBILLINAE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; ISCHEMIC ATTACK, TRANSIENT; MALE; NERVE TISSUE PROTEINS; PRESYNAPTIC TERMINALS; PROTEIN PRECURSORS; SYNUCLEINS;

EID: 0344301876     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00033-X     Document Type: Article

References (21)

1. George J.M., Jin H., Woods W.S., Clayton D.F. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron. 15:1995;361-372.
2. H. Han, P.H. Weinreb, P.T. Lansbury Jr., The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by β-amyloid: is NAC a common trigger or target in neurodegenerative disease? Chem. Biol. (1995) 163-169.
3. Ishimaru H., Takahashi A., Ikarashi Y., Maruyama Y. Effect of transient cerebral ischemia on acetylcholine release in the gerbil hippocampus. NeuroReport. 5:1994;601-604.
4. Ishimaru H., Takahashi A., Ikarashi Y., Maruyama Y. Temporal changes in extracellular acetylcholine and CA1 pyramidal cells in gerbil hippocampus following transient cerebral ischemia. Brain Res. 639:1994;66-72.
5. Ishimaru H., Takahashi A., Ikarashi Y., Maruyama Y. Immunohistochemical and neurochemical studies of hippocampal cholinergic neurons after ischaemia. NeuroReport. 6:1995;557-560.
6. H. Ishimaru, A. Takahashi, Y. Ikarashi, Y. Maruyama, NGF delays rather than prevents the cholinergic terminal damage and delayed neuronal death after ischemia, Brain Res. (in press).
7. Ishimaru H., Ishikawa K., Haga S., Shoji M., Ohe Y., Haga C., Sasaki A., Takahashi A., Maruyama Y. Accumulation of apolipoprotein E and β-amyloid-like protein in a trace of the hippocampal CA1 pyramidal cell layer after ischaemic delayed neuronal death. NeuroReport. 7:1996;3063-3067.
8. Iwai A., Yamamoto M., Masliah E., Saitoh T. Non-Aβ component of Alzheimer's disease amyloid (NAC) is amyloidogenetic. Biochemistry. 34:1995;10139-10145.
9. Iwai A., Masliah E., Sundsmo M.P., DeTeresa R., Mallory M., Salmon D.P., Saitoh T. The synaptic protein NACP is abnormally expressed during the progression of Alzheimer's disease. Brain Res. 720:1996;230-234.
10. Iwai A., Masliah E., Yoshimoto M., Ge N., Flanagan L., Rohan de Silva H.A., Kittel A., Saitoh T. The precursor protein of Non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron. 14:1995;467-475.
11. Jakes R., Spillantini M.G., Goederk M. Identification of two distinct synucleins from human brain. FEBS Lett. 345:1994;27-32.
12. Jendroska K., Poewe W., Daniel S.E., Pluess J., Iwerssen-Schmidt H., Paulsen J., Barthel S., Schelosky L., Cervós-Navarro J., DeArmond S.J. Ischemic stress induces deposition of amyloid β immunoreactivity in human brain. Acta Neuropathol. 90:1995;461-466.
13. Kang J., Lemaire H.-G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:1987;733-736.
14. Maroteaux L., Scheller R.H. The rat brain synuclein; family of proteins transiently associated with neuronal membrane. Mol. Brain Res. 11:1991;335-343.
15. Masliah E., Iwai A., Mallory M., Uéda K., Saitoh T. Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease. Am. J. Pathol. 148:1996;201-210.
16. Näslund J., Thyberg J., Tjernberg L.O., Wernstedt C., Karlström A.R., Bogdanovic N., Gandy S.E., Lannfelt L., Terenius L., Nordstedt C. Characterization of stable complexes involving apolipoprotein E and the amyloid β peptide in Alzheimer's disease brain. Neuron. 15:1995;219-228.
17. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejla A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di-Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
18. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30:1991;572-580.
19. Uéda K., Fukushima H., Masliah E., Xia Y., Iwai A., Yoshimoto M., Otero D.A.C., Kondo J., Ihara Y., Saitoh T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90:1993;11282-11286.
20. Whitehouse P.J., Price D.L., Struble R.G. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 215:1982;1237-1239.
21. Yoshimoto M., Iwai A., Kang D., Otero D.A.C., Xia Y., Saitoh T. NACP, the precursor protein of the non-amyloid β/A4 protein (Aβ) component of Alzheimer disease amyloid, binds Aβ and stimulates Aβ aggregation. Proc. Natl. Acad. Sci. U.S.A. 92:1995;9141-9145.